ST Pharm Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
7,461
5,466
25,189
61,426
44,997
Depreciation, Depletion & Amortization
4,182
4,304
6,161
10,785
11,568
Other Funds
-
-
-
-
224
Funds from Operations
17,088
4,784
45,011
70,853
55,662
Changes in Working Capital
4,517
43
11,369
21,264
68
Net Operating Cash Flow
12,571
4,827
33,642
49,590
55,594
Capital Expenditures
3,159
22,927
22,398
16,033
27,735
Sale of Fixed Assets & Businesses
10
199
9
8
98
Purchase/Sale of Investments
100
1,872
14,627
51,830
57
Net Investing Cash Flow
3,248
24,600
33,165
93,576
27,581
Cash Dividends Paid - Total
-
1,143
1,048
2,945
9,242
Issuance/Reduction of Debt, Net
7,000
20,217
9,981
42,520
20
Net Financing Cash Flow
7,000
19,074
8,933
86,768
9,038
Net Change in Cash
2,325
701
9,361
43,392
17,106
Free Cash Flow
9,468
18,081
11,539
33,561
27,899
Net Assets from Acquisitions
-
-
25,500
25,500
-
Other Sources
-
-
98
60
-
Change in Capital Stock
-
-
-
132,233
-
Exchange Rate Effect
2
1
49
610
1,869
Other Uses
-
-
-
281
-

About ST Pharm Co.

View Profile
Address
#802, Siheunggongdan 1-Na
Siheung-si GY 15086
Korea, Republic Of
Employees -
Website http://www.stpharm.co.kr
Updated 09/14/2018
ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic Active Pharmaceutical Ingredients (APIs), Fine Chemical, and Bio. The New Drug CMO business offers services such as process optimization, documentation support, and validation.